[HTML][HTML] The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients …

A Mikstacki, O Zakerska-Banaszak… - Journal of Applied …, 2017 - Springer
Abstract Propofol (2, 6-diisopropylphenol) is one of the safest and most commonly used
anaesthetic agents for intravenous general anaesthesia. However, in clinical practice, a …

The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children

D Pavlovic, I Budic, T Jevtovic Stoimenov… - Pharmacogenomics …, 2020 - Taylor & Francis
Purpose This study was conducted to determine the effect of UGT1A9 98T> C, CYP2B6
516G> T and CYP2C9 430C> T genetic polymorphisms on the pharmacokinetics of propofol …

Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability

AL Mourão, FG de Abreu, M Fiegenbaum - European journal of drug …, 2016 - Springer
Abstract Background and Objectives Propofol is the most commonly used hypnotic
worldwide, but its effective dose varies greatly between individuals. The present study …

Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia

I Loryan, M Lindqvist, I Johansson, M Hiratsuka… - European journal of …, 2012 - Springer
Purpose The basis of high intersubject variability of propofol metabolism is unclear.
Therefore, we examined the influence of genetic polymorphisms of the key metabolizing …

[HTML][HTML] Clinical importance of potential genetic determinants affecting propofol pharmacokinetics and pharmacodynamics

I Budic, T Jevtovic Stoimenov, D Pavlovic… - Frontiers in …, 2022 - frontiersin.org
Interindividual variability in response to drugs used in anesthesia has long been considered
the rule, not the exception. It is important to mention that in anesthesiology, the variability in …

Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age

F Kansaku, T Kumai, K Sasaki, M Yokozuka… - Drug metabolism and …, 2011 - Elsevier
Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …

[HTML][HTML] Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general …

O Zakerska-Banaszak, M Skrzypczak-Zielinska… - Scientific reports, 2017 - nature.com
The individual response of patients to propofol results from the influence of genetic factors.
However, the state of knowledge in this matter still remains insufficient. The aim of our study …

Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics

A Kanaya, T Sato, N Fuse, H Yamaguchi, N Mano… - Journal of …, 2018 - Springer
Purpose Propofol is one of the most widely used fast-acting intravenously administered
anesthetics. However, although large inter-individual differences in dose requirements and …

Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment

MS Khan, EL Zetterlund, H Gréen… - Basic & clinical …, 2014 - Wiley Online Library
A variety of techniques have been developed to monitor the depth of anaesthesia. Propofol's
pharmacokinetics and response vary greatly, which might be explained by genetic …

[HTML][HTML] Association of polymorphisms in pharmacogenetic candidate genes with propofol susceptibility

Q Zhong, X Chen, Y Zhao, R Liu, S Yao - Scientific reports, 2017 - nature.com
Significant individual susceptibility to intravenous anesthetic propofol exists. The etiology of
individual variability in the response to propofol may be influenced by genetic …